Cross-Cutting Engineering

Package Integrity and Sterility

Verify seal integrity and sterility assurance for medical, consumer, and drug-delivery packages using validated leak methods.

We combine dye penetration, bubble emission, decay-style leak checks, microbial barrier evidence, and conditioning links for package validation and troubleshooting.

ISO 17025USP <1207>ASTM F1929ASTM F2096Reviewed 2026-05-16
Request a quoteSubmit a sample

Purpose & when to use

Package integrity and sterility-support testing evaluates whether sealed packages, sterile barrier systems, and containers resist leaks or microbial ingress using dye penetration, bubble emission, vacuum or pressure decay, and microbial barrier challenge methods. Programs align to USP <1207>, ASTM F1929, ASTM F2096, and ISO 11607 under ISO 17025 quality controls. Use this service when package condition affects sterility, shelf life, or change-control evidence:

  1. USP <1207> container closure integrity checks for sterile barrier systems using leak-method sensitivity, controls, and acceptance criteria.
  2. ASTM F1929 dye penetration studies for pouches, trays, or seal channels where visual leak-path evidence supports package validation.
  3. ASTM F2096 bubble emission screening for porous or flexible packages using immersion, pressure, and gross-leak observations.
  4. ISO 11607 package validation support for sterile medical packaging using integrity, microbial barrier, and aging-linked evidence.
  5. ISO 17025 change-control investigations for films, adhesives, seal settings, or suppliers using matched lots and documented fixtures.

Use package integrity and sterility-support testing when package design, seal process, distribution stress, or supplier change could alter barrier performance. The method plan fixes sensitivity, controls, replicates, conditioning state, and reporting language before samples enter testing.

Built for sterile packaging and sealed containers

Integrity programs serve medical-device, drug-delivery, aerosol, and product-packaging teams where USP, ASTM, ISO, sterility, or quality-system expectations shape barrier evidence.

  • Sterile barriersPouches, trays, blister packs
  • Medical packagesDevice and kit packaging
  • Aerosol containersCans, valves, fitments
  • Drug deliveryPackages and delivery systems
  • Product packagesSealed consumer formats

Instrumentation & measurement ranges

Platforms are selected by package geometry, target defect size, material compatibility, and the decision the study supports.

10 - 75 µmvisual

Dye penetration and ingress fixtures

Seal-channel and package-path screening with dye exposure, dwell control, rinse handling, and documented visual inspection for defects where dye methods fit the material.

0 - 30 kPapressure

Bubble emission and immersion systems

Pressurized package immersion with observation windows, pressure holds, and gross-leak records for flexible, porous, or sealed packages suited to ASTM F2096-style screening.

0 - 100 kPadecay

Vacuum and pressure decay leak checks

Fixture-based decay measurements for packages or containers where a quantitative leak signal, stable fixture seal, and package-specific acceptance criteria are available.

0 - 14 dincubation

Microbial barrier and sterility-support workflows

Challenge, incubation, and observation workflows used when package barrier performance or sterility-support evidence requires microbiological controls and defined run validity.

Test method options

MethodStrengthsTradeoffAligned with
Container closure integrity method selection
  • USP <1207> framing connects package risk, method sensitivity, acceptance criteria, and control strategy before testing starts.
  • Supports sterile barrier and container decisions where leak detection must be tied to package design and use condition.
Requires package-specific sensitivity rationale and controls before results can support sterility-risk conclusions.
USP <1207>
Dye penetration seal-channel evaluation
  • ASTM F1929 gives direct visual evidence of channels, seal voids, and edge defects in compatible porous packages.
  • Fast feedback supports seal-parameter troubleshooting across pouches, trays, films, adhesives, and supplier lots.
Applicability depends on package materials, dye visibility, seal geometry, and controlled dwell or rinse handling.
ASTM F1929
Bubble emission gross-leak screening
  • ASTM F2096 supports pressure-based gross-leak detection for flexible and porous packages that tolerate immersion.
  • Useful for rapid screening after sealing changes, distribution stress, or visible package damage.
Gross-leak screening does not replace finer leak methods when the sterility decision needs higher sensitivity.
ASTM F2096
Sterile barrier validation support
  • ISO 11607 framing links package design, sealing process, aging state, and barrier evidence for medical packaging.
  • Microbial barrier controls and post-conditioning integrity checks support validation and root-cause investigations.
Study duration and sample demand increase when aging, distribution stress, or microbial challenge legs are included.
ISO 11607

Setup configurations

A package integrity study starts with a protocol that fixes package type, seal process, lot identity, conditioning state, method sensitivity target, replicate count, positive and negative controls, and acceptance criteria. The setup connects each leak or microbial barrier outcome to a known package configuration and sample history.

Sample matrix

Package format, material, seal width, lot, supplier, fill state, and packaging process variables documented before testing.

Device interfaces

Fixtures, adapters, seal isolation, immersion orientation, and pressure or vacuum interfaces matched to package geometry.

Environmental controls

As-received, aged, stressed, or post-shipping states defined with conditioning records and hold times.

Sample numbers

Replicates per lot, condition, and control group sized to the package-risk question and acceptance rule.

Chain of custody

Receipt, labeling, storage, conditioning, test sequence, and final disposition recorded for each package group.

Quality anchors for package barrier evidence

Package integrity programs need the quality-system anchor and method frame defined before setup begins. These four anchors shape fixtures, controls, acceptance criteria, and report language.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, and method control.
  • USP <1207>AlignedContainer closure integrity method selection and sensitivity rationale.
  • ASTM F1929AlignedDye penetration assessment for porous package seal leaks.
  • ASTM F2096AlignedBubble emission screening for gross leaks in packages.

Key data outputs & reporting

Every package integrity and sterility-support study delivers method-specific outcomes plus the setup records needed to interpret them. Reports state package configuration, fixture design, conditioning state, controls, acceptance criteria, replicate results, defect observations, microbial barrier outcomes when included, and uncertainty contributors for quantitative leak checks. Results are organized by lot, package type, condition, method, and pass/fail or measured response.

Primary outputs

  • Leak outcomes by package, lot, condition, and method, including pass/fail calls and quantitative decay values where applicable.
  • Defect-location notes such as seal channel, puncture, fitment, valve, flange, or tray-lid pathway when identifiable.
  • Microbial barrier or sterility-support observations, including growth/no-growth records and control validity where included.
  • Condition comparisons across as-received, aged, stressed, post-shipping, supplier, or seal-parameter groups.

Deliverables

#FormatContents
01PDF reportMethod frame, setup, controls, results, acceptance criteria, and interpretation.
02CSV / XLSX datasetsReplicate outcomes, leak values, condition metadata, and control records.
03ImagesDefect photos, dye evidence, setup views, or sample-condition documentation.

QA / QC & data integrity

Integrity results are only defensible when package identity, controls, fixtures, and environmental history stay traceable across every condition tested. QA / QC records therefore cover positive and negative controls, instrument checks, sample handling, conditioning logs, run validity, and acceptance criteria from receipt through final report.

Positive controls with known defects and negative controls with intact packages where the method supports them.

Instrument calibration and verification records for decay, pressure, vacuum, timing, and environmental controls.

Defined run-validity checks for dye dwell, immersion pressure, leak-rate stability, and microbial challenge controls.

Sample identity, lot, package condition, conditioning state, and chain-of-custody records for every test article.

Deviation handling for damaged samples, invalid controls, fixture leaks, excursions, and out-of-spec observations.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Package integrity questions usually come from packaging, quality, regulatory, product-development, and manufacturing teams deciding which leak or barrier evidence fits a sterile barrier, container, pouch, tray, or sealed product. These answers cover method selection, dye and bubble tests, microbial barrier support, aging links, sample counts, and deliverables. Reach out if your package format or regulatory frame needs a different setup.

Q.Which integrity method should I use?
A.Method selection depends on package material, geometry, target defect size, and decision risk. Dye penetration and bubble emission are common screens; decay-style checks can add quantitative evidence when fixtures and acceptance criteria are available.
Q.Can you test packages after aging or shipping stress?
A.Yes. Integrity testing can be run as received, after accelerated aging, after real-time storage pulls, or after distribution stress. The report ties each result to its conditioning state and sample history.
Q.Do you support microbial barrier evidence?
A.Yes, when fit for purpose. We define challenge, controls, incubation, and run-validity criteria in the protocol so microbial barrier observations are interpreted with the integrity data.
Q.How many samples are needed?
A.Sample count depends on package variability, lots, conditions, controls, and acceptance rules. We build the replicate plan around the package-risk question before samples are shipped.
Q.What do I receive after testing?
A.Deliverables usually include a PDF report, CSV or XLSX result tables, control records, setup notes, defect images where useful, and acceptance-criteria discussion tied to the selected standards.

Standards & guidance

Package integrity and sterility-support programs are scoped around package format, barrier claim, method sensitivity, and validation decision. ARE Labs treats ISO 17025 as the quality-system anchor and aligns package work to USP <1207>, ASTM F1929, ASTM F2096, and ISO 11607 where applicable. The cards below list the primary standards used for leak detection, seal evaluation, and sterile barrier evidence.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, traceable records, calibration control, and uncertainty contributorsView standard ->Container Closure Integrity - Aligned

USP <1207>

Container closure integrity method selection, validation concepts, and leak-risk evidenceView standard ->Package Integrity - Aligned

ASTM F1929

Dye penetration testing for detecting seal leaks in porous medical packagesView standard ->Package Integrity - Aligned

ASTM F2096

Bubble emission leak testing for gross leaks in packaging by internal pressurizationView standard ->Sterile Barrier Systems - Aligned

ISO 11607

Packaging for terminally sterilized medical devices, including sterile barrier system validationView standard ->

Related services & devices

Service

Stability and Accelerated Aging

Pairs with integrity checks when storage, temperature, humidity, or aging state may change package barrier performance.Read more ->Devices

Medical Devices

Sterile medical devices and kits use barrier evidence to support package validation, change control, and shelf-life decisions.Read more ->Service

Shelf-Life Studies

Adds scheduled pulls when leakage, seal drift, or microbial barrier evidence must be trended over storage time.Read more ->Devices

Spray & Aerosol

Aerosol containers, valves, and sealed spray packages may need leak checks before transport, stability, or release decisions.Read more ->